Preclinical Drug Testing in Reduced Gravity: Pilot Partners Wanted

CeleroSpace is building a new preclinical testing capability using reduced gravity as an experimental layer for advanced human models such as organ-on-chip, organoids and 3D tissues.

Our first validation work focuses on an osteochondral / osteoarthritis-on-chip model, comparing standard lab conditions with simulated microgravity to assess changes in tissue integrity, remodeling and stress response.

We are looking to connect with:

Research centres and hospitals working with advanced in vitro models or NAMs

CROs interested in differentiated preclinical testing services

Pharma and biotech teams exploring new ways to de-risk candidates or validate disease models

Space / microgravity partners interested in biological payloads and drug-testing applications

We are open to scientific feedback, pilot studies, use-case co-development, validation partnerships and joint grant proposals.

Initial areas of interest include osteoarthritis / osteochondral models, with future expansion into liver toxicity, oncology, organoids and other complex disease models.